Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Crit Rev Oncog. 2014;19(0):281–315. doi: 10.1615/critrevoncog.2014011455

FIG. 2.

FIG. 2

Schematic diagram of CRLX101, a nanopharmaceutical comprised of camptothecin conjugated to a linear, cy clodextrin-poly(ethylene glycol) (CD-PEG) copolymer and formulated into nanoparticles. Reprinted from Ref. 105. Copyright 2011, with permission from Elsevier.

HHS Vulnerability Disclosure